Combination therapy in hormone-refractory prostate cancer

被引：0
作者：
Daniel P. Petrylak
机构：
来源：
Current Oncology Reports | 2001年 / 3卷 / 5期
关键词：
Prostate Cancer; Hydrocortisone; Docetaxel; Mitoxantrone; Estramustine;
D O I：
10.1007/s11912-001-0033-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 453
相关论文
共 50 条
  • [21] Therapeutic Efficacy of Curcumin/TRAIL Combination Regimen for Hormone-Refractory Prostate Cancer
    Andrzejewski, Tanja
    Deeb, Dorrah
    Gao, Xiaohua
    Danyluk, Andrew
    Arbab, Ali S.
    Dulchavsky, Scott A.
    Gautam, Subhash C.
    ONCOLOGY RESEARCH, 2008, 17 (06) : 257 - 267
  • [22] The role of bisphosphonates in hormone-refractory prostate cancer
    Fred Saad
    Pierre Karakiewicz
    Paul Perrotte
    World Journal of Urology, 2005, 23 : 14 - 18
  • [23] Therapeutic options for hormone-refractory prostate cancer
    Miller, K.
    Boergermann, C.
    Thueroff, J.
    Albers, P.
    Wirth, M.
    UROLOGE, 2006, 45 (05): : 580 - +
  • [24] Treatment with prednisolone of hormone-refractory prostate cancer
    Fuse, H
    Nozaki, T
    Fujiuchi, Y
    Mizuno, I
    Nagakawa, O
    Okumura, A
    ARCHIVES OF ANDROLOGY, 2006, 52 (01): : 35 - 38
  • [25] Octreotide in the management of hormone-refractory prostate cancer
    Vainas, IG
    CHEMOTHERAPY, 2001, 47 : 109 - 126
  • [26] The androgen receptor in hormone-refractory prostate cancer
    Mao, Hai-Lei
    Zhu, Zhi-Qi
    Chen, Charlie Degui
    ASIAN JOURNAL OF ANDROLOGY, 2009, 11 (01) : 68 - 73
  • [27] The role of bisphosphonates in hormone-refractory prostate cancer
    Saad, F
    Karakiewicz, P
    Perrotte, P
    WORLD JOURNAL OF UROLOGY, 2005, 23 (01) : 14 - 18
  • [28] Clinical trials in metastatic hormone-refractory prostate cancer: Improving docetaxel therapy by targeting bone-related growth factors
    Daniel P. Petrylak
    Current Oncology Reports, 2007, 9 (3) : 211 - 212
  • [29] New hope for patients with metastatic hormone-refractory prostate cancer
    de Wit, Ronald
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (15) : 817 - 823
  • [30] Therapeutic options for hormone-refractory prostate cancer
    Miller K.
    Börgermann C.
    Thüroff J.
    Albers P.
    Wirth M.
    Der Urologe, 2006, 45 (5): : 580 - 585
12345